News Detail
New Delhi, 21 June 2024: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of May, has revealed that the carbapenem antibiotic Meropenem is linked with adverse drug reactions (ADRs) named Acute Generalized Exanthematous Pustulo......
View Details
Source : DrugsControl Media Services
drug safety alert
meropenem
Indian Pharmacopoeia Commission
carbapenem antibiotic
adverse drug reactions
ADRs
Acute Generalized Exanthematous Pustulosis
Pharmacovigilance Programme of India
PvPI database
antibiotic
Related News
- The coming booster for Indian pharma stocks: US Biosecure Act (10-09-2024)
- Telangana DCA officials seized 635 bottles of Glycoril cough syrup, along with printed labels (10-09-2024)
- GST reduced on Cancer life-saving drugs from 12% to 5% (10-09-2024)
- Penicillin G & Clavulanic acid Plant to start production soon: DoP (10-09-2024)
- Use latest tech to develop Green Pharma City: CM Revanth Reddy to officials (10-09-2024)
- FSSAI issues draft to include natamycin as preservative in additives norms (10-09-2024)
- Domestic formulations biz expected to grow 9-10% over next decade: Glenmark (09-09-2024)
- Biological drugs don't harm, but fix immunity: Experts (09-09-2024)
- Mumbai: Anti-Narcotics Cell Seizes 300 Codeine-Based Cough Syrup Bottles in Dharavi area (08-09-2024)
- Police seize 100 bottles of Eskuf cough syrup at Agartala railway station (08-09-2024)